Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Prepaid Assets (2019 - 2025)

Keros Therapeutics filings provide 7 years of Prepaid Assets readings, the most recent being $2.4 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 90.86% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 million, a 90.86% decrease, with the full-year FY2025 number at $2.4 million, down 90.86% from a year prior.
  • Prepaid Assets hit $2.4 million in Q4 2025 for Keros Therapeutics, down from $22.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $26.8 million in Q2 2024 to a low of $210000.0 in Q4 2021.
  • Median Prepaid Assets over the past 5 years was $6.7 million (2022), compared with a mean of $9.8 million.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 4200.0% in 2023 and later plummeted 90.86% in 2025.
  • Keros Therapeutics' Prepaid Assets stood at $210000.0 in 2021, then skyrocketed by 3099.52% to $6.7 million in 2022, then skyrocketed by 138.18% to $16.0 million in 2023, then soared by 63.84% to $26.2 million in 2024, then plummeted by 90.86% to $2.4 million in 2025.
  • The last three reported values for Prepaid Assets were $2.4 million (Q4 2025), $22.3 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.